ID   SH-SY5Y
AC   CVCL_0019
SY   SHSY5Y; SHSY-5Y; SH-Sy5y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental
DR   BTO; BTO:0000793
DR   CLO; CLO_0009015
DR   EFO; EFO_0002717
DR   MCCL; MCC:0000421
DR   CLDB; cl4287
DR   CLDB; cl4288
DR   CLDB; cl4289
DR   CLDB; cl4290
DR   AddexBio; C0005004/63
DR   ATCC; CRL-2266
DR   BCRJ; 0223
DR   BioSample; SAMN10987717
DR   CCLE; SHSY5Y_AUTONOMIC_GANGLIA
DR   CCRID; 3111C0001CCC000026
DR   CCRID; 3131C0001000700097
DR   CCRID; 3142C0001000000486
DR   CCRID; 3142C0001000000964
DR   CCRID; 3153C0001000000223
DR   CCTCC; GDC0210
DR   Cell_Model_Passport; SIDM01236
DR   CGH-DB; 63-1
DR   ChEMBL-Cells; CHEMBL3307740
DR   ChEMBL-Targets; CHEMBL614910
DR   CLS; 300154/p822_SH-SY5Y
DR   Cosmic; 688084
DR   Cosmic; 1019933
DR   Cosmic; 1167410
DR   Cosmic; 1212536
DR   Cosmic; 2058109
DR   Cosmic; 2239470
DR   Cosmic; 2393641
DR   DepMap; ACH-001188
DR   DSMZ; ACC-209
DR   ECACC; 94030304
DR   ENCODE; ENCBS264AAA
DR   GEO; GSM231608
DR   GEO; GSM231609
DR   GEO; GSM231610
DR   GEO; GSM231611
DR   GEO; GSM231612
DR   GEO; GSM231613
DR   GEO; GSM231614
DR   GEO; GSM231615
DR   GEO; GSM231616
DR   GEO; GSM231617
DR   GEO; GSM231618
DR   GEO; GSM231619
DR   GEO; GSM231620
DR   GEO; GSM231621
DR   GEO; GSM231622
DR   GEO; GSM231623
DR   GEO; GSM231624
DR   GEO; GSM231625
DR   GEO; GSM231626
DR   GEO; GSM231627
DR   GEO; GSM231628
DR   GEO; GSM231629
DR   GEO; GSM231630
DR   GEO; GSM231631
DR   GEO; GSM231632
DR   GEO; GSM231633
DR   GEO; GSM231634
DR   GEO; GSM231635
DR   GEO; GSM231636
DR   GEO; GSM231637
DR   GEO; GSM231638
DR   GEO; GSM231639
DR   GEO; GSM231640
DR   GEO; GSM231641
DR   GEO; GSM231642
DR   GEO; GSM231643
DR   GEO; GSM231644
DR   GEO; GSM231645
DR   GEO; GSM231646
DR   GEO; GSM231647
DR   GEO; GSM231648
DR   GEO; GSM231649
DR   GEO; GSM231650
DR   GEO; GSM231651
DR   GEO; GSM231652
DR   GEO; GSM231653
DR   GEO; GSM231654
DR   GEO; GSM231655
DR   GEO; GSM231656
DR   GEO; GSM231657
DR   GEO; GSM231658
DR   GEO; GSM231659
DR   GEO; GSM231660
DR   GEO; GSM231661
DR   GEO; GSM231662
DR   GEO; GSM231663
DR   GEO; GSM231664
DR   GEO; GSM231665
DR   GEO; GSM231666
DR   GEO; GSM231667
DR   GEO; GSM231668
DR   GEO; GSM231669
DR   GEO; GSM231670
DR   GEO; GSM231671
DR   GEO; GSM231672
DR   GEO; GSM231673
DR   GEO; GSM692874
DR   GEO; GSM887570
DR   GEO; GSM888653
DR   GEO; GSM1622294
DR   GEO; GSM2371253
DR   GEO; GSM2394368
DR   ICLC; HTL95013
DR   IZSLER; BS TCL 232
DR   KCB; KCB 2006107YJ
DR   KCLB; 22266
DR   LINCS_LDP; LCL-2000
DR   Lonza; 132
DR   MetaboLights; MTBLS455
DR   NCBI_Iran; C611
DR   PharmacoDB; SHSY5Y_1374_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003914
DR   PRIDE; PXD004452
DR   TOKU-E; 3118
DR   Wikidata; Q7390126
RX   PubMed=1354203;
RX   PubMed=2535691;
RX   PubMed=2846152;
RX   PubMed=4748425;
RX   PubMed=6137586;
RX   PubMed=10630978;
RX   PubMed=15150091;
RX   PubMed=15720811;
RX   PubMed=16120276;
RX   PubMed=16822308;
RX   PubMed=18957096;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=23421552;
RX   PubMed=24466371;
RX   PubMed=25182563;
RX   PubMed=25730103;
RX   PubMed=25884760;
RX   PubMed=26342562;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=28118852;
RX   PubMed=28350380;
RX   PubMed=28601559;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   https://en.wikipedia.org/wiki/SH-SY5Y
WW   http://www.proteinatlas.org/learn/cellines
WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/SH-SY5Y_Farnham_protocol.pdf
WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-101.html
WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sh-sy5y
WW   https://www.phe-culturecollections.org.uk/media/114601/sh-sy5y-cell-line-profile.pdf
WW   https://www.kerafast.com/product/3180/trk-sh-sy5y-neuroblastoma-cell-lines
WW   http://www.cellresource.cn/fdetail.aspx?id=26
WW   http://www.cellresource.cn/fdetail.aspx?id=665
WW   http://www.cellresource.cn/fdetail.aspx?id=1133
WW   http://www.cellresource.cn/fdetail.aspx?id=2174
WW   http://www.cellresource.cn/fdetail.aspx?id=2201
CC   Problematic cell line: Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 810.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Characteristics: There seems to be differences in the retinoic acid (RA)-induced neuronal phenotype of SH-SY5Y cells from ATCC and ECACC. After 5 days of RA treatment, ECACC cells are slightly larger in size and contains significant amount of neuroblastic (N-type) cells and a small fraction of epithelial (S-type) cells (PubMed=18957096).
CC   Doubling time: >55 hours (DSMZ).
CC   Sequence variation: ALK p.Phe1174Leu (c.3522C>A) (PubMed=28350380).
CC   Omics: Deep antibody staining analysis.
CC   Omics: Deep exome analysis.
CC   Omics: Deep proteome analysis.
CC   Omics: Deep tyrosine phosphoproteome analysis.
CC   Omics: Deep RNAseq analysis.
CC   Omics: GPI-anchored proteins analysis by proteomics.
CC   Omics: Mitochondrial proteome analysis by 2D-DE/MS.
CC   Omics: N-glycan profiling.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis.
CC   Genome ancestry: African=0%; Native American=1.17%; East Asian, North=0.35%; East Asian, South=0.1%; South Asian=0.08%; European, North=69.09%; European, South=29.2% (PubMed=30894373).
CC   Misspelling: SH-SY5; Occasionally.
CC   Derived from metastatic site: Bone marrow.
ST   Source(s): ATCC; CCRID; CLS; DSMZ; ECACC; KCLB
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 18,22
ST   D13S317: 11
ST   D16S539: 8,13
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 17,19
ST   D2S441: 11,11.3
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D6S1043: 12,18
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 23.2,24
ST   Penta D: 10,12
ST   Penta E: 7,11
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 12-03-20; Version: 32
//
RX   PubMed=1354203; DOI=10.1002/ijc.2910520116;
RA   Gross N., Favre S., Beck D., Meyer M.;
RT   "Differentiation-related expression of adhesion molecules and
RT   receptors on human neuroblastoma tissues, cell lines and variants.";
RL   Int. J. Cancer 52:85-91(1992).
//
RX   PubMed=2535691;
RA   Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A.;
RT   "Phenotypic diversification in human neuroblastoma cells: expression
RT   of distinct neural crest lineages.";
RL   Cancer Res. 49:219-225(1989).
//
RX   PubMed=2846152;
RA   Preis P.N., Saya H., Nadasdi L., Hochhaus G., Levin V., Sadee W.;
RT   "Neuronal cell differentiation of human neuroblastoma cells by
RT   retinoic acid plus herbimycin A.";
RL   Cancer Res. 48:6530-6534(1988).
//
RX   PubMed=4748425;
RA   Biedler J.L., Helson L., Spengler B.A.;
RT   "Morphology and growth, tumorigenicity, and cytogenetics of human
RT   neuroblastoma cells in continuous culture.";
RL   Cancer Res. 33:2643-2652(1973).
//
RX   PubMed=6137586; DOI=10.1093/jnci/71.4.741;
RA   Ross R.A., Spengler B.A., Biedler J.L.;
RT   "Coordinate morphological and biochemical interconversion of human
RT   neuroblastoma cells.";
RL   J. Natl. Cancer Inst. 71:741-747(1983).
//
RX   PubMed=10630978; DOI=10.1667/0033-7587(2000)153[0062:FORIMI]2.0.CO;2;
RA   Akudugu J.M., Slabbert J.P., Serafin A., Bohm L.;
RT   "Frequency of radiation-induced micronuclei in neuronal cells does not
RT   correlate with clonogenic survival.";
RL   Radiat. Res. 153:62-67(2000).
//
RX   PubMed=15150091; DOI=10.1158/0008-5472.CAN-03-0809;
RA   Schaefer K.-L., Brachwitz K., Wai D.H., Braun Y., Diallo R.,
RA   Korsching E., Eisenacher M., Voss R., van Valen F., Baer C., Selle B.,
RA   Spahn L., Liao S.-K., Lee K.A.W., Hogendoorn P.C.W., Reifenberger G.,
RA   Gabbert H.E., Poremba C.;
RT   "Expression profiling of t(12;22) positive clear cell sarcoma of soft
RT   tissue cell lines reveals characteristic up-regulation of potential
RT   new marker genes including ERBB3.";
RL   Cancer Res. 64:3395-3405(2004).
//
RX   PubMed=15720811; DOI=10.1593/neo.04310;
RA   Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.-F.,
RA   Biedler J.L., Cheung N.-K.V., Ross R.A.;
RT   "Characteristics of stem cells from human neuroblastoma cell lines and
RT   in tumors.";
RL   Neoplasia 6:838-845(2004).
//
RX   PubMed=16120276; DOI=10.1016/S1567-7249(01)00007-1;
RA   Scheffler N.K., Miller S.W., Carroll A.K., Anderson C., Davis R.E.,
RA   Ghosh S.S., Gibson B.W.;
RT   "Two-dimensional electrophoresis and mass spectrometric identification
RT   of mitochondrial proteins from an SH-SY5Y neuroblastoma cell line.";
RL   Mitochondrion 1:161-179(2001).
//
RX   PubMed=16822308; DOI=10.1186/1471-2407-6-177;
RA   Dam V., Morgan B.T., Mazanek P., Hogarty M.D.;
RT   "Mutations in PIK3CA are infrequent in neuroblastoma.";
RL   BMC Cancer 6:177-177(2006).
//
RX   PubMed=18957096; DOI=10.1186/1756-0500-1-95;
RA   Nishida Y., Adati N., Ozawa R., Maeda A., Sakaki Y., Takeda T.;
RT   "Identification and classification of genes regulated by
RT   phosphatidylinositol 3-kinase- and TRKB-mediated signalling pathways
RT   during neuronal differentiation in two subtypes of the human
RT   neuroblastoma cell line SH-SY5Y.";
RL   BMC Res. Notes 1:95-95(2008).
//
RX   PubMed=22213050; DOI=10.1002/ijc.27415;
RA   Gawecka J.E., Geerts D., Koster J., Caliva M.J., Sulzmaier F.J.,
RA   Opoku-Ansah J., Wada R.K., Bachmann A.S., Ramos J.W.;
RT   "PEA15 impairs cell migration and correlates with clinical features
RT   predicting good prognosis in neuroblastoma.";
RL   Int. J. Cancer 131:1556-1568(2012).
//
RX   PubMed=22460905; DOI=10.1038/nature11003;
RA   Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A.,
RA   Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A.,
RA   Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J.,
RA   Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E.,
RA   Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J.,
RA   Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C.,
RA   Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C.,
RA   Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N., Mesirov J.P.,
RA   Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L.,
RA   Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R.,
RA   Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.;
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=23421552; DOI=10.1089/ast.2012.0822;
RA   Zhang Y.-Q., Wang H.-B., Lai C.-J., Wang L., Deng Y.-L.;
RT   "Comparative proteomic analysis of human SH-SY5Y neuroblastoma cells
RT   under simulated microgravity.";
RL   Astrobiology 13:143-150(2013).
//
RX   PubMed=24466371; DOI=10.1593/tlo.13544;
RA   Loschmann N., Michaelis M., Rothweiler F., Zehner R., Cinatl J.,
RA   Voges Y., Sharifi M., Riecken K., Meyer J., von Deimling A.,
RA   Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr.;
RT   "Testing of SNS-032 in a panel of human neuroblastoma cell lines with
RT   acquired resistance to a broad range of drugs.";
RL   Transl. Oncol. 6:685-696(2013).
//
RX   PubMed=25182563; DOI=10.1007/s13577-014-0096-9;
RA   Jiang T., Wang H.-L.;
RT   "Identification of cross-contamination in SH-SY5Y cell line.";
RL   Hum. Cell 27:176-178(2014).
//
RX   PubMed=25730103; DOI=10.1021/pr5011718;
RA   Hu Y., Mayampurath A., Khan S., Cohen J.K., Mechref Y.,
RA   Volchenboum S.L.;
RT   "N-linked glycan profiling in neuroblastoma cell lines.";
RL   J. Proteome Res. 14:2074-2081(2015).
//
RX   PubMed=25884760; DOI=10.1371/journal.pcbi.1004130;
RA   Palacios-Moreno J., Foltz L., Guo A., Stokes M.P., Kuehn E.D.,
RA   George L., Comb M., Grimes M.L.;
RT   "Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN
RT   in endosomes and lipid rafts.";
RL   PLoS Comput. Biol. 11:E1004130-E1004130(2015).
//
RX   PubMed=26342562; DOI=10.1016/j.scr.2015.08.008;
RA   Ross R.A., Walton J.D., Han D., Guo H.-F., Cheung N.-K.V.;
RT   "A distinct gene expression signature characterizes human
RT   neuroblastoma cancer stem cells.";
RL   Stem Cell Res. 15:419-426(2015).
//
RX   PubMed=26972028; DOI=10.1016/j.jprot.2016.03.008;
RA   Masuishi Y., Kimura Y., Arakawa N., Hirano H.;
RT   "Identification of glycosylphosphatidylinositol-anchored proteins and
RT   omega-sites using TiO2-based affinity purification followed by
RT   hydrogen fluoride treatment.";
RL   J. Proteomics 139:77-83(2016).
//
RX   PubMed=27141528; DOI=10.1016/j.dib.2016.04.001;
RA   Masuishi Y., Kimura Y., Arakawa N., Hirano H.;
RT   "Data for identification of GPI-anchored peptides and omega-sites in
RT   cancer cell lines.";
RL   Data Brief 7:1302-1305(2016).
//
RX   PubMed=28118852; DOI=10.1186/s13024-017-0149-0;
RA   Xicoy H., Wieringa B., Martens G.J.M.;
RT   "The SH-SY5Y cell line in Parkinson's disease research: a systematic
RT   review.";
RL   Mol. Neurodegener. 12:10-10(2017).
//
RX   PubMed=28350380; DOI=10.1038/sdata.2017.33;
RA   Harenza J.L., Diamond M.A., Adams R.N., Song M.M., Davidson H.L.,
RA   Hart L.S., Dent M.H., Fortina P., Reynolds C.P., Maris J.M.;
RT   "Transcriptomic profiling of 39 commonly-used neuroblastoma cell
RT   lines.";
RL   Sci. Data 4:170033-170033(2017).
//
RX   PubMed=28601559; DOI=10.1016/j.cels.2017.05.009;
RA   Bekker-Jensen D.B., Kelstrup C.D., Batth T.S., Larsen S.C.,
RA   Haldrup C., Bramsen J.B., Sorensen K.D., Hoyer S., Orntoft T.F.,
RA   Andersen C.L., Nielsen M.L., Olsen J.V.;
RT   "An optimized shotgun strategy for the rapid generation of
RT   comprehensive human proteomes.";
RL   Cell Syst. 4:587-599.e4(2017).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//